Internal Server Error

About IR21 Capital

IR21 Capital is a venture capital firm It primarily invests in Singapore based startups. Its investments are spread across a wide range of sectors from Blockchain Technology to High Tech and FinTech. Overall, IR21 Capital portfolio has seen 1 acquisition, namely Chainlink.
Key Metrics
Portfolio Count
Portfolio Locations
Portfolio Acquisitions

IR21 Capital's List of Top Investments

IR21 Capital has a portfolio of 7 companies. Their most notable investments include Chainlink and Neo.Their portfolio spans across Singapore, Cayman Islands, China and 3 more locations. They have invested in Blockchain Technology, High Tech, FinTech and 5 other sectors. Here is the list of top investments by IR21 Capital:
Decentralized Oracle network to support smart contracts. It provides inputs and outputs of data for smart contracts on a blockchain. Smart contracts can connect with API and datasets. It also facilitates the smart contract to send payments to bank accounts and payment networks.

Key facts about Chainlink

2. Neo

Blockchain-based infrastructure for the development of decentralized applications. It is a public chain that is designed to record and transfer digital assets. It is a decentralized and distributed network protocol that can be used to digitalize assets or shares and accomplish financial business objectives through peer-to-peer networks such as registration and issuing, making transactions, settlement, and payment.

Key facts about Neo

3. Aave

Decentralized crypto lending marketplace for consumers. It offers ETHLend that allows users to borrow funds against cryptocurrency collateral and retain upside instead of selling. Provides access fee reductions and participates in the future governance of Aave protocols. It allows users to originate cash loans to borrowers against cryptocurrency and digital asset collaterals. Also offers developer tools for building tokenized debit applications on Ethereum.

Key facts about Aave

  • Founded Year: 2009
  • Location: London (United Kingdom)
  • Annual Revenue: £1M - £10M as on Dec 31, 2024
  • Stage: Series B
  • Total Funding till date: $29.5M
  • Employee Count: 144 as on Jul 31, 2026
  • Investors: 2020 Ventures, SWS Venture Capital and 40 Others
  • Latest Funding Round: Series B, Oct 12, 2020, $*****
  • Highlight: Editors' Pick
Provider of a blockchain network for DeFi based on Web 3.0. Features crypto assets issuance, liquidity management, community activities, and DAO governance. Also provides reward-based staking platforms for NFTs.

Key facts about TrustFi

Triall is a blockchain based platform for the clinical ecosystem. It provides a database for the storage of medical information of different clinical research. It delivers five core pillars research data integrity, oversight and advanced decision-making, patient engagement, optimized partner selection, and meeting current and future unmet needs. Features include data and document verifier, integrated trial management dashboard, partner selection, and management platform, and incubator program.

Key facts about Triall

Acquired companies in IR21 Capital's Portfolio

1 company from IR21 Capital's portfolio has been acquired. The most recent acquisition was Chainlink in Sep 2021 by Hyphen for $*****.
Here are IR21 Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 12, 2021
-
-
2201

FAQs about IR21 Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford